X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA AUROBINDO PHARMA ALEMBIC PHARMA/
AUROBINDO PHARMA
 
P/E (TTM) x 26.5 18.0 147.7% View Chart
P/BV x 6.1 5.8 103.7% View Chart
Dividend Yield % 0.8 0.4 219.1%  

Financials

 ALEMBIC PHARMA   AUROBINDO PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
AUROBINDO PHARMA
Mar-16
ALEMBIC PHARMA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs7921,541 51.4%   
Low Rs443582 76.1%   
Sales per share (Unadj.) Rs167.0237.5 70.3%  
Earnings per share (Unadj.) Rs38.233.9 112.7%  
Cash flow per share (Unadj.) Rs42.040.6 103.5%  
Dividends per share (Unadj.) Rs4.002.50 160.0%  
Dividend yield (eoy) %0.60.2 275.1%  
Book value per share (Unadj.) Rs84.9120.6 70.4%  
Shares outstanding (eoy) m188.52585.17 32.2%   
Bonus/Rights/Conversions -PREF-  
Price / Sales ratio x3.74.5 82.7%   
Avg P/E ratio x16.231.3 51.6%  
P/CF ratio (eoy) x14.726.2 56.2%  
Price / Book Value ratio x7.38.8 82.6%  
Dividend payout %10.57.4 142.0%   
Avg Mkt Cap Rs m116,383621,041 18.7%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m4,21415,508 27.2%   
Avg. sales/employee Rs ThNM10,457.6-  
Avg. wages/employee Rs ThNM1,167.1-  
Avg. net profit/employee Rs ThNM1,491.6-  
INCOME DATA
Net Sales Rs m31,487138,961 22.7%  
Other income Rs m551,663 3.3%   
Total revenues Rs m31,542140,624 22.4%   
Gross profit Rs m10,06032,056 31.4%  
Depreciation Rs m7223,926 18.4%   
Interest Rs m372,568 1.4%   
Profit before tax Rs m9,35627,225 34.4%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1607,444 29.0%   
Profit after tax Rs m7,19419,820 36.3%  
Gross profit margin %31.923.1 138.5%  
Effective tax rate %23.127.3 84.4%   
Net profit margin %22.814.3 160.2%  
BALANCE SHEET DATA
Current assets Rs m15,066100,015 15.1%   
Current liabilities Rs m7,67474,759 10.3%   
Net working cap to sales %23.518.2 129.2%  
Current ratio x2.01.3 146.7%  
Inventory Days Days67107 62.4%  
Debtors Days Days41110 37.1%  
Net fixed assets Rs m8,23752,350 15.7%   
Share capital Rs m377585 64.4%   
"Free" reserves Rs m15,41667,707 22.8%   
Net worth Rs m16,00570,567 22.7%   
Long term debt Rs m08,472 0.0%   
Total assets Rs m24,594156,994 15.7%  
Interest coverage x255.211.6 2,199.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.30.9 144.6%   
Return on assets %29.414.3 206.2%  
Return on equity %44.928.1 160.0%  
Return on capital %58.737.7 155.5%  
Exports to sales %55.751.0 109.2%   
Imports to sales %10.418.8 55.3%   
Exports (fob) Rs m17,55170,927 24.7%   
Imports (cif) Rs m3,28326,193 12.5%   
Fx inflow Rs m17,81171,015 25.1%   
Fx outflow Rs m5,31828,799 18.5%   
Net fx Rs m12,49342,216 29.6%   
CASH FLOW
From Operations Rs m9,30417,596 52.9%  
From Investments Rs m-3,105-13,801 22.5%  
From Financial Activity Rs m-1,959-198 987.9%  
Net Cashflow Rs m4,2403,597 117.9%  

Share Holding

Indian Promoters % 74.1 54.1 137.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 8.0 36.5%  
FIIs % 9.1 27.7 32.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 10.2 136.3%  
Shareholders   49,328 69,601 70.9%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES SHASUN LTD  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS